Hofseth Biocare ASA(HOFBF)
$0.120.00 (0.00%)
HOFBF
Hofseth Biocare ASA financials statements
$0.12
At close:0.00 (0.00%)
Hofseth Biocare ASA (HOFBF) Ratios
6 Followers
Hofseth Biocare ASA Ratios
HOFBF's free cash flow for Q3 2026 was kr-69.00M. For the 2026 fiscal year, HOFBF's free cash flow was decreased by kr-210.00K and operating cash flow was kr-68.79M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.67 | 0.67 | 0.52 | 1.02 | 1.13 |
| Quick Ratio | 0.42 | 0.33 | 0.19 | 0.34 | 0.53 |
| Cash Ratio | 0.28 | 0.15 | 0.09 | 0.17 | 0.31 |
| Solvency Ratio | -0.20 | -0.32 | -0.20 | -0.41 | -0.35 |
| Operating Cash Flow Ratio | -0.16 | -0.06 | 0.01 | -0.26 | -0.41 |
| Short-Term Operating Cash Flow Coverage | -0.33 | -0.20 | 0.02 | -83.64 | -25.53 |
| Net Current Asset Value | kr -308.01M | kr -168.00M | kr -217.98M | kr -87.25M | kr -105.28M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.76 | 0.50 | 0.72 | 0.25 | 0.33 |
| Debt-to-Equity Ratio | -4.02 | 2.85 | 6.71 | 0.70 | 0.99 |
| Debt-to-Capital Ratio | 1.33 | 0.74 | 0.87 | 0.41 | 0.50 |
| Long-Term Debt-to-Capital Ratio | 2.17 | 0.29 | 0.01 | 0.01 | 0.14 |
| Financial Leverage Ratio | -5.27 | 5.69 | 9.33 | 2.76 | 2.95 |
| Debt Service Coverage Ratio | -0.53 | -1.07 | -0.35 | -9.36 | -7.43 |
| Interest Coverage Ratio | -4.94 | -7.27 | -13.59 | -12.92 | -12.62 |
| Debt to Market Cap | 0.47 | 0.10 | 0.17 | 0.00 | 0.01 |
| Interest Debt Per Share | 0.79 | 0.45 | 0.73 | 0.30 | 0.42 |
| Net Debt to EBITDA | -3.19 | -2.14 | -4.10 | -0.77 | -1.05 |
| Profitability Margins | |||||
| Gross Profit Margin | -12.76% | 34.13% | 22.67% | 23.67% | 26.36% |
| EBIT Margin | -44.29% | -39.68% | -50.87% | -105.80% | -133.62% |
| EBITDA Margin | -28.80% | -26.42% | -32.19% | -80.54% | -100.12% |
| Operating Profit Margin | -44.29% | -44.28% | -52.61% | -106.78% | -135.32% |
| Pretax Profit Margin | -52.94% | -48.68% | -54.75% | -114.07% | -144.34% |
| Net Profit Margin | -53.01% | -47.94% | -54.74% | -114.06% | -144.34% |
| Continuous Operations Profit Margin | -53.01% | -48.68% | -54.75% | -114.07% | -144.34% |
| Net Income Per EBT | 100.13% | 98.49% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 119.54% | 109.93% | 104.05% | 106.82% | 106.66% |
| Return on Assets (ROA) | -34.21% | -36.15% | -27.35% | -33.43% | -30.40% |
| Return on Equity (ROE) | 180.22% | -205.52% | -255.06% | -92.38% | -89.65% |
| Return on Capital Employed (ROCE) | -73.63% | -65.91% | -74.17% | -53.86% | -44.73% |
| Return on Invested Capital (ROIC) | -39.62% | -49.09% | -31.85% | -51.00% | -42.41% |
| Return on Tangible Assets | -34.49% | -41.28% | -31.86% | -39.20% | -34.85% |
| Earnings Yield | -24.86% | -17.66% | -10.31% | -11.14% | -5.12% |
| Efficiency Ratios | |||||
| Receivables Turnover | 11.82 | 11.99 | 13.12 | 8.56 | 3.91 |
| Payables Turnover | 3.03 | 1.81 | 2.73 | 0.63 | 0.52 |
| Inventory Turnover | 4.80 | 3.03 | 1.83 | 0.79 | 0.71 |
| Fixed Asset Turnover | 1.73 | 1.87 | 1.18 | 0.71 | 0.47 |
| Asset Turnover | 0.65 | 0.75 | 0.50 | 0.29 | 0.21 |
| Working Capital Turnover Ratio | -3.75 | -2.90 | -3.32 | 10.52 | 0.95 |
| Cash Conversion Cycle | -13.39 | -50.75 | 94.14 | -73.40 | -95.24 |
| Days of Sales Outstanding | 30.87 | 30.43 | 27.81 | 42.64 | 93.45 |
| Days of Inventory Outstanding | 76.11 | 120.37 | 199.94 | 462.63 | 513.77 |
| Days of Payables Outstanding | 120.38 | 201.56 | 133.61 | 578.67 | 702.45 |
| Operating Cycle | 106.98 | 150.81 | 227.75 | 505.28 | 607.21 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.09 | -0.02 | 0.01 | -0.12 | -0.17 |
| Free Cash Flow Per Share | -0.16 | -0.03 | -0.03 | -0.17 | -0.28 |
| Dividend Paid and CapEx Coverage Ratio | -1.52 | -2.40 | 0.34 | -2.54 | -1.64 |
| Capital Expenditure Coverage Ratio | -1.52 | -2.40 | 0.34 | -2.54 | -1.64 |
| Operating Cash Flow Coverage Ratio | -0.13 | -0.06 | 0.01 | -0.43 | -0.44 |
| Operating Cash Flow to Sales Ratio | -0.15 | -0.04 | 0.01 | -0.38 | -0.71 |
| Free Cash Flow Yield | -11.75% | -1.99% | -1.09% | -5.11% | -4.03% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.00 | -5.67 | -9.70 | -8.97 | -19.52 |
| Price-to-Sales (P/S) Ratio | 2.13 | 2.71 | 5.31 | 10.24 | 28.18 |
| Price-to-Book (P/B) Ratio | -7.25 | 11.64 | 24.75 | 8.29 | 17.50 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -8.51 | -50.31 | -91.59 | -19.59 | -24.81 |
| Price-to-Operating Cash Flow Ratio | -14.11 | -71.46 | 375.04 | -27.30 | -39.97 |
| Price-to-Earnings Growth (PEG) Ratio | -0.40 | -0.51 | 0.36 | -1.57 | -1.51 |
| Enterprise Value Multiple | -10.60 | -12.41 | -20.60 | -13.47 | -29.20 |
| Enterprise Value | 776.35M | 844.14M | 1.29B | 1.31B | 2.56B |
| EV to EBITDA | -10.60 | -12.41 | -20.60 | -13.47 | -29.20 |
| EV to Sales | 3.05 | 3.28 | 6.63 | 10.85 | 29.23 |
| EV to Free Cash Flow | -12.18 | -60.77 | -114.33 | -20.77 | -25.73 |
| EV to Operating Cash Flow | -20.19 | -86.31 | 468.12 | -28.94 | -41.45 |
| Tangible Book Value Per Share | -0.19 | 0.05 | -0.04 | 0.23 | 0.24 |
| Shareholders’ Equity Per Share | -0.18 | 0.15 | 0.11 | 0.40 | 0.39 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Revenue Per Share | 0.62 | 0.63 | 0.49 | 0.32 | 0.24 |
| Net Income Per Share | -0.33 | -0.30 | -0.27 | -0.37 | -0.35 |
| Tax Burden | 1.00 | 0.98 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.20 | 1.23 | 1.08 | 1.08 | 1.08 |
| Research & Development to Revenue | 0.00 | 0.06 | 0.06 | 0.11 | 0.14 |
| SG&A to Revenue | 0.34 | 0.32 | 0.11 | 0.15 | 0.36 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.29 | 0.08 | -0.03 | 0.33 | 0.49 |
Currency in NOK

